Radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma
Intended for healthcare professionals
Clinical Previous     Next

Radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma

Louise Causer Clinical nurse specialist, Oncology nuclear medicine at Southampton University Hospital Trust, Hampshire and the Royal Marsden Hospital, London

Cancers of the immune system (lymphomas) are extremely sensitive to radiation. Medical research over the last decade has lead to the development of monoclonal antibodies that can target lymphoma cells being attached to radioactive isotopes that help destroy those cells. Such treatment is known as radioimmunotherapy and this article describes its use for non-Hodgkin’s lymphoma. Nurses need to become familiar with how radioimmunotherapy differs from conventional chemotherapy.

Cancer Nursing Practice. 4, 9, 27-33. doi: 10.7748/cnp2005.11.4.9.27.c149

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more